SAM CHUN DANG PHARM CO. LTD Logo

SAM CHUN DANG PHARM CO. LTD

000250 | KO

Overview

Corporate Details

ISIN(s):
KR7000250001
LEI:
Country:
South Korea
Address:
경기도 화성시 향남읍 제약공단2길 71, 화성시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

No description available.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-19 00:00
Share Issue/Capital Change
[기재정정]주요사항보고서(교환사채권발행결정)
Korean 30.5 KB
2025-09-19 00:00
Transaction in Own Shares
[기재정정]주요사항보고서(자기주식처분결정)
Korean 40.4 KB
2025-09-19 00:00
Transaction in Own Shares
자기주식처분결과보고서
Korean 22.0 KB
2025-09-19 00:00
Share Issue/Capital Change
증권발행결과(자율공시)
Korean 7.4 KB
2025-08-27 00:00
Capital/Financing Update
주요사항보고서(교환사채권발행결정)
Korean 25.0 KB
2025-08-27 00:00
Transaction in Own Shares
주요사항보고서(자기주식처분결정)
Korean 32.5 KB
2025-08-14 00:00
Interim / Quarterly Report
반기보고서 (2025.06)
Korean 2.2 MB
2025-07-30 00:00
AGM Information
임시주주총회결과
Korean 9.2 KB
2025-07-24 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 100.9 KB
2025-07-24 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 25.2 KB
2025-07-24 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.1 KB
2025-07-07 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 61.1 KB
2025-06-30 00:00
Regulatory Filings
[기재정정]단일판매ㆍ공급계약체결(자율공시)
Korean 19.9 KB
2025-06-24 00:00
Director's Dealing
임원ㆍ주요주주특정증권등거래계획보고서
Korean 41.3 KB
2025-06-24 00:00
Director's Dealing
임원ㆍ주요주주특정증권등거래계획보고서
Korean 41.2 KB

Automate Your Workflow. Get a real-time feed of all SAM CHUN DANG PHARM CO. LTD filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for SAM CHUN DANG PHARM CO. LTD

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for SAM CHUN DANG PHARM CO. LTD via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Access Bio, Inc. Logo
Develops and manufactures rapid diagnostic tests for infectious diseases for global health.
United States of America
950130
ACHIEVE LIFE SCIENCES, INC. Logo
Developing cytisinicline, a plant-based treatment for smoking cessation and nicotine addiction.
United States of America
ACHV
AC Immune SA Logo
Developing precision medicine to diagnose, treat, and prevent neurodegenerative diseases.
United States of America
ACIU
Aclaris Therapeutics, Inc. Logo
A clinical-stage biopharma developing novel drugs for immuno-inflammatory diseases.
United States of America
ACRS
Acrivon Therapeutics, Inc. Logo
Develops precision cancer therapies by matching patients to drugs using its proteomics platform.
United States of America
ACRV
Acticor Biotech Logo
Clinical-stage biopharma developing a first-in-class drug for thrombotic diseases like stroke.
France
ALACT
Actinium Pharmaceuticals, Inc. Logo
Develops targeted radiotherapies for advanced cancers like AML and prostate cancer.
United States of America
ATNM
ACTUATE THERAPEUTICS, INC. Logo
Clinical-stage biopharma developing a novel GSK-3 inhibitor for hard-to-treat cancers.
United States of America
ACTU
AcuCort AB Logo
Develops a rapid oral film for acute allergies, croup, and chemo-induced nausea.
Sweden
ACUC
Acumen Pharmaceuticals, Inc. Logo
Clinical-stage biopharma developing an antibody therapy for Alzheimer's by targeting toxic AβOs.
United States of America
ABOS

Talk to a Data Expert

Have a question? We'll get back to you promptly.